Delivery Order SPE2DB22D1202-SPE2DB23FHNS0

Award Date 5/8/23
Potential Completion Date 5/9/23
Potential Value $50K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of RABAVERT RABIES VACC W-DILUENTS to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $2,095.80, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 3, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with...
This federal contract award is for the delivery of RABAVERT RABIES VACC W-DILUENTS, with a ceiling value of $20,958.00. The contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This is a Firm Fixed Price Delivery Order contract, with a period of performance through February 25, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug...
This federal contract award is for the delivery of RABAVERT Rabies Vaccine with diluents, awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $38,606, is a Firm Fixed Price Delivery Order placed by the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of October 24, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award is for the delivery of RABAVERT rabies vaccine with diluents, awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA). The $3,860.60 firm fixed price delivery order has a completion date of November 1, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026 to provide a comprehensive range of medical commodities,...
The federal contract award is for the delivery of RABAVERT rabies vaccine with diluents, awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,448.58 Firm Fixed Price Delivery Order contract was awarded by the Defense Logistics Agency (DLA), a defense agency, on October 24, 2024, with a completion date of October 25, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen is the...
This federal contract award is for the delivery of RABAVERT rabies vaccine with diluents, placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corp as the prime contractor. The firm-fixed-price delivery order has a ceiling value of $3,860.60 and a completion date of November 7, 2024. The contract is not designated as a set-aside. AmerisourceBergen, a major pharmaceutical distributor, maintains a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of RABAVERT RABIES VACCINE WITH DILUENTS, valued at $1,940.37, awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract has an ultimate completion date of November 13, 2024, and is structured as a firm fixed-price delivery order. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...
This federal contract award is for the delivery of RABAVERT RABIES VACC W-DILUENTS to the Defense Logistics Agency (DLA). The $2,095.80 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of February 20, 2025 and is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite...
This federal contract award is for the delivery of RABAVERT rabies vaccine with diluents, valued at $20,290.20. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on March 9, 2022 by the Defense Logistics Agency (DLA). Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of...
This federal contract award is for the delivery of RABAVERT RABIES VACCINE WITH DILUENTS to the Defense Logistics Agency (DLA), a defense agency. The $48,309.89 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, on June 25, 2024, with a completion date of June 26, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB23FHNS0
    Delivery Order

This federal contract award is for the delivery of RABAVERT RABIES VACCINE WITH DILUENTS, valued at $50,393.66. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract has an ultimate completion date of May 9, 2023 and is a Firm Fixed Price delivery order. This contract award is not associated with any set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/9/25, 10:13 AM